Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient's own biology to deliver rare disease therapeutics, today
General Electric Company (NYSE: GE) shares traded lower on Tuesday before ultimately closing slightly higher after the company reported fourth-quarter earnings.